Fund Holdings — DIADEMA PARTNERS LP

Total Portfolio Value:
$283.17M
Total Bought:
$130.97M
Total Sold:
$96.78M
Net Transaction:
+$34.19M
Notable People:
Timothy Beau Bassett
Securities
▲▼
SharesValue
Q1 2026
▲▼
Q2 2026
▲▼
Change
▲▼
Q1 2026
▲▼
Q2 2026
▲▼
Weight (%)
▲▼
Change
▲▼
United Therapeutics Corporation(UTHR)27,30352,989+25,686$16.19M$28.71M10.14%+$12.52M
Revolution Medicines, Inc.(RVMD)80,872139,218+58,346$7.86M$26.07M9.21%+$18.21M
ABIVAX Société Anonyme(ABVX)75,944163,644+87,700$8.22M$21.60M7.63%+$13.38M
Cogent Biosciences, Inc.(COGT)322,764493,664+170,900$12.42M$19.10M6.75%+$6.68M
BridgeBio Pharma, Inc.(BBIO)250,0000-250,000$18.57M$18.62M6.58%+$55.0K
BioMarin Pharmaceutical Inc.(BMRN)148,229312,846+164,617$8.37M$17.90M6.32%+$9.53M
Viking Therapeutics, Inc.(VKTX)525,181441,808-83,373$17.09M$17.23M6.09%+$145.5K
Edgewise Therapeutics, Inc.(EWTX)0272,214+272,214$0$11.06M3.91%+$11.06M
Kodiak Sciences Inc.(KOD)192,962218,117+25,155$7.36M$8.50M3.00%+$1.14M
Immunocore Holdings plc(IMCR)193,189254,863+61,674$5.82M$8.09M2.86%+$2.27M
4D MOLECULAR THERAPEUTICS IN0571,107+571,107$0$7.60M2.68%+$7.60M
Arcus Biosciences, Inc.(RCUS)238,142223,810-14,332$5.14M$6.90M2.44%+$1.76M
Johnson & Johnson(JNJ)53,77122,000-31,771$13.14M$5.59M1.97%-$7.56M
Novo Nordisk A/S(NVO)14,577100,000+85,423$520.7K$4.81M1.70%+$4.29M
Corvus Pharmaceuticals, Inc.(CRVS)244,811294,811+50,000$3.58M$4.40M1.56%+$822.9K
Relay Therapeutics, Inc.(RLAY)0230,677+230,677$0$4.32M1.52%+$4.32M
Zymeworks Inc.(ZYME)142,132142,1320$3.56M$3.72M1.31%+$156.3K
BIOAGE LABS INC60,000146,334+86,334$1.05M$3.59M1.27%+$2.54M
Taysha Gene Therapies, Inc.(TSHA)0522,619+522,619$0$3.56M1.26%+$3.56M
Nurix Therapeutics, Inc.(NRIX)0121,539+121,539$0$2.95M1.04%+$2.95M
CORBUS PHARMACEUTICALS HLDGS439,957301,264-138,693$4.13M$2.83M1.00%-$1.31M
Indivior Pharmaceuticals, Inc.(INDV)71,37667,512-3,864$2.18M$2.77M0.98%+$594.5K
INVENTIVA SA352,399740,786+388,387$1.94M$2.73M0.96%+$790.7K
Oruka Therapeutics, Inc.(ORKA)027,799+27,799$0$2.65M0.93%+$2.65M
Vaxcyte, Inc.(PCVX)25,07145,071+20,000$1.46M$2.62M0.93%+$1.16M
RELMADA THERAPEUTICS INC200,842361,367+160,525$1.40M$2.50M0.88%+$1.10M
Vera Therapeutics, Inc.(VERA)057,608+57,608$0$2.47M0.87%+$2.47M
CONTINEUM THERAPEUTICS INC0119,733+119,733$0$1.96M0.69%+$1.96M
BICYCLE THERAPEUTICS PLC476,424462,724-13,700$2.21M$1.96M0.69%-$248.7K
Monte Rosa Therapeutics, Inc.(GLUE)187,30778,391-108,916$3.08M$1.90M0.67%-$1.18M
Viridian Therapeutics, Inc.(VRDN)0100,000+100,000$0$1.84M0.65%+$1.84M
MACROGENICS INC600,000374,403-225,597$1.73M$1.73M0.61%-$4.3K
PROQR THRAPEUTICS N V
SHS EURO
180,083926,016+745,933$291.7K$1.72M0.61%+$1.43M
SPRUCE BIOSCIENCES INC10,00030,000+20,000$653.5K$1.62M0.57%+$966.5K
ARDELYX INC0303,025+303,025$0$1.55M0.55%+$1.55M
CUE BIOPHARMA INC048,369+48,369$0$1.53M0.54%+$1.53M
Mineralys Therapeutics, Inc.(MLYS)26,34756,347+30,000$713.7K$1.52M0.54%+$806.5K
PROTHENA CORP PLC
SHS
0149,482+149,482$0$1.46M0.52%+$1.46M
VOYAGER THERAPEUTICS INC423,642413,642-10,000$1.64M$1.45M0.51%-$187.5K
UNICYCIVE THERAPEUTICS INC106,083303,676+197,593$698.0K$1.42M0.50%+$726.2K
PHATHOM PHARMACEUTICALS INC54,650129,950+75,300$607.2K$1.41M0.50%+$802.8K
Spyre Therapeutics, Inc.(SYRE)015,000+15,000$0$1.33M0.47%+$1.33M
CYBIN INC0200,000+200,000$0$1.32M0.47%+$1.32M
EQUILLIUM INC433,844400,282-33,562$867.7K$1.28M0.45%+$413.2K
XERIS BIOPHARMA HOLDINGS INC132,746132,7460$769.9K$1.05M0.37%+$281.4K
PHARVARIS N V
COM
29,32129,3210$828.3K$1.01M0.36%+$185.6K
Harmony Biosciences Holdings, Inc.(HRMY)92,86426,864-66,000$2.60M$978.1K0.35%-$1.62M
CARTESIAN THERAPEUTICS INC087,057+87,057$0$907.1K0.32%+$907.1K
Rigel Pharmaceuticals, Inc.(RIGL)022,816+22,816$0$892.6K0.32%+$892.6K
Summit Therapeutics Inc.(SMMT)060,000+60,000$0$874.2K0.31%+$874.2K
Precigen, Inc.(PGEN)55,293135,293+80,000$214.0K$771.2K0.27%+$557.2K
Definium Therapeutics, Inc.(DFTX)015,451+15,451$0$726.8K0.26%+$726.8K
PELTHOS THERAPEUTICS INC24,77324,7730$520.5K$700.1K0.25%+$179.6K
PEPGEN INC150,925373,284+222,359$267.1K$671.9K0.24%+$404.8K
ENLIVEN THERAPEUTICS INC24510,000+9,755$9.6K$507.5K0.18%+$497.9K
CONNECT BIOPHARMA HLDGS LTD200,690196,985-3,705$525.8K$468.8K0.17%-$57.0K
LARIMAR THERAPEUTICS INC166,637146,637-20,000$749.9K$447.2K0.16%-$302.6K
CELLECTAR BIOSCIENCES INC0138,341+138,341$0$384.6K0.14%+$384.6K
FOGHORN THERAPEUTICS INC79,94466,908-13,036$382.1K$326.5K0.12%-$55.6K
AYTU BIOPHARMA INC353,077148,546-204,531$963.9K$319.4K0.11%-$644.5K
OCUGEN INC200,000200,0000$362.0K$306.0K0.11%-$56.0K
UroGen Pharma Ltd.(URGN)23,1557,137-16,018$416.3K$262.6K0.09%-$153.7K
Amgen Inc.(AMGN)0102,701+102,701$0$214.6K0.08%+$214.6K
HERON THERAPEUTICS INC0458,723+458,723$0$195.8K0.07%+$195.8K
TALPHERA INC153,563153,5630$114.7K$158.2K0.06%+$43.5K
ANNEXON INC132,91627,516-105,400$736.4K$157.1K0.06%-$579.2K
MONOPAR THERAPEUTICS INC1,6301,6300$89.3K$150.9K0.05%+$61.6K
LAKELAND INDS INC014,108+14,108$0$150.8K0.05%+$150.8K
UPSTREAM BIO INC21,60919,093-2,516$194.5K$132.1K0.05%-$62.4K
MeiraGTx Holdings plc(MGTX)08,368+8,368$0$113.1K0.04%+$113.1K
JATT II ACQUISITION CORP09,021+9,021$0$102.5K0.04%+$102.5K
KAILERA THERAPEUTICS INC03,621+3,621$0$79.8K0.03%+$79.8K
MannKind Corporation(MNKD)186,60316,003-170,600$457.2K$68.2K0.02%-$389.0K
ENTERA BIO LTD23,26023,2600$25.8K$41.2K0.01%+$15.4K
ARS PHARMACEUTICALS INC04,860+4,860$0$38.9K0.01%+$38.9K
APREA THERAPEUTICS INC044,907+44,907$0$36.0K0.01%+$36.0K
TVARDI THERAPEUTICS INC016,607+16,607$0$31.6K0.01%+$31.6K
NEXTCURE INC07,742+7,742$0$12.4K0.00%+$12.4K
AbbVie Inc.(ABBV)24,0580-24,058$5.23M$0—-$5.23M
Alkermes plc(ALKS)50,0000-50,000$1.77M$0—-$1.77M
ATRIUM THERAPEUTICS INC2,5120-2,512$33.6K$0—-$33.6K
BridgeBio Pharma, Inc.(BBIO)85,3110-85,311$6.34M$0—-$6.34M
CAPRICOR THERAPEUTICS INC78,8510-78,851$2.40M$0—-$2.40M
Celcuity Inc.(CELC)5,3140-5,314$606.5K$0—-$606.5K
CLIMB BIO INC286,1260-286,126$1.96M$0—-$1.96M
COMPASS Pathways plc(CMPS)31,8850-31,885$176.3K$0—-$176.3K
Corcept Therapeutics Incorporated(CORT)10,0000-10,000$403.1K$0—-$403.1K
CUE BIOPHARMA INC131,9970-131,997$30.3K$0—-$30.3K
Dianthus Therapeutics, Inc.(DNTH)10,0000-10,000$839.2K$0—-$839.2K
Eli Lilly and Company(LLY)6,0000-6,000$5.52M$0—-$5.52M
ENANTA PHARMACEUTICALS INC64,9520-64,952$820.3K$0—-$820.3K
EUPRAXIA PHARMACEUTICALS INC40,0000-40,000$289.6K$0—-$289.6K
EYEPOINT INC178,5450-178,545$2.30M$0—-$2.30M
GH Research PLC(GHRS)26,8360-26,836$377.3K$0—-$377.3K
Incyte Corporation(INCY)78,0290-78,029$7.34M$0—-$7.34M
INOVIO PHARMACEUTICALS INC562,6650-562,665$979.0K$0—-$979.0K
Jazz Pharmaceuticals plc(JAZZ)54,7550-54,755$10.35M$0—-$10.35M
LIPOCINE INC NEW50,0000-50,000$399.5K$0—-$399.5K
Maze Therapeutics, Inc.(MAZE)15,0000-15,000$447.8K$0—-$447.8K
PASSAGE BIO INC19,5300-19,530$153.3K$0—-$153.3K
Page 1 of 2
DIADEMA PARTNERS LP — 13F Holdings — Q2 2026 | TickerTrail